NCT05068960View on ClinicalTrials.gov

Postoperative Pain Control in Total Shoulder Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
Total Shoulder Arthroplasty
Interventions
DRUG

Liposomal bupivacaine

Addition of liposomal bupivacaine to the interscalene block for extended pain control following total shoulder arthroplasty

DRUG

Bupivacaine

Interscalene block with bupivacaine for pain control following total shoulder arthroplasty

Trial Locations (1)

92037

Scripps Clinic, La Jolla

All Listed Sponsors
lead

Scripps Clinic

OTHER

NCT05068960 - Postoperative Pain Control in Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter